Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
Important supply updates
At this time, COVID-19 is not having an impact on GSK supply in the UK.
Please see below for details of products where we are currently experiencing supply issues:
Product name |
PIP Code |
Status |
Estimated recovery date |
|---|---|---|---|
| AUGMENTIN Vial 1.2g x 10 | 2342616 | Out of stock | TBC |
| BETNOVATE OINTMENT 0.1% 1x100g | 29496 | Out of stock | Mid Nov 2020 |
| ENGERIX B Vials x 10 | 153171 | Being Discontinued | No Replenishment |
| FLIXOTIDE Nebules 0.5mg/2ml 1x10 | 2589588 | Out of stock | Late Feb 2021 |
| FLIXOTIDE Nebules 2mg/2ml 1X10 | 2589570 | Out of stock | Late Feb 2021 |
| FORTUM Injection 1gm | 381988 | Out of stock | Q1 2021 |
| FORTUM Injection 2gm | 385278 | Out of stock | Q1 2021 |
| FORTUM Injection 3gm | 2075208 | Being Discontinued | No Replenishment |
| FORTUM Injection 500mg | 434092 | Out of stock | Q1 2021 |
| PENTOSTAM Inj 100ml x 1 | 214395 | Discontinued | No Replenishment |
| TIMENTIN Vials 3.2g x 4 | 4192 | Not marketed in the UK | |
| ZANTAC Syrup 300ml | 413229 | Out of stock | TBC |
| ZANTAC Inj 25mg/ml 5x2ml | 453720 | Out of stock | TBC |
| ZYBAN Tablets 150mg x 60 | 2709848 | Out of stock | Early Dec 2020 |
If you have any queries about the availability of a product, please contact your wholesaler.
Further information
If you require further information, please contact our UK Customer Contact Centre (customercontactuk@gsk.com); Freephone: 0800 221 441 or chat to a member of our team online.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.
